Paul Sirajuddin

发表

Design, Synthesis, and Structure–Activity Relationships of Pyridoquinazolinecarboxamides as RNA Polymerase I Inhibitors

J. Barrow, K. Peltonen, M. Laiho, 2014, Journal of medicinal chemistry.

DNA intercalator BMH-21 inhibits RNA polymerase I independent of DNA damage response

J. Barrow, K. Peltonen, M. Laiho, 2014, Oncotarget.

Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI

A. Üren, A. Ozcan, S. Karam, 2012, Cell cycle.

Assessment of Multiple Types of DNA Damage in Human Placentas from Smoking and Non-smoking Women in the Czech

Miriam, D. DeMarini, R. Sram, 2011 .

Assessment of multiple types of DNA damage in human placentas from smoking and nonsmoking women in the Czech Republic

D. DeMarini, R. Sram, M. Poirier, 2011, Environmental and molecular mutagenesis.

Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.

M. Schiffman, P. Castle, A. Glass, 2007, Mutation research.

Effective targeting of RNA polymerase I in treatment‐resistant prostate cancer

C. Bieberich, A. D. De Marzo, M. Laiho, 2019, The Prostate.

Novel Assay to Detect RNA Polymerase I Activity In Vivo

Baoyan Bai, A. D. De Marzo, M. Laiho, 2017, Molecular Cancer Research.

VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells

T. MacDonald, A. Üren, R. Glazer, 2011, Cancer biology & therapy.

Metastasis‐associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells

A. Tischler, K. Pacak, S. Ohta, 2008, Molecular carcinogenesis.

Small Molecule BMH-Compounds That Inhibit RNA Polymerase I and Cause Nucleolar Stress

K. Peltonen, M. Laiho, S. Jäämaa, 2014, Molecular Cancer Therapeutics.

Induction of apoptosis and autophagy by the small molecule inhibitor VMY-1-103 in cancer cell lines and reduction of tumor growth in vivo

Paul Sirajuddin, 2013 .

The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells

Chin-Lee Wu, Richard J Lee, C. Albanese, 2014, Oncotarget.

The induction of the p 53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells

Chin-Lee Wu, Richard J Lee, C. Albanese, 2014 .

A cautionary note on using N-acetylcysteine as an antagonist to assess isothiocyanate-induced reactive oxygen species-mediated apoptosis.

Xiantao Wang, Lixin Mi, N. Gan, 2010, Analytical biochemistry.

VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells

M. Lisanti, C. Albanese, M. Avantaggiati, 2010, Cancer biology & therapy.

Induction of apoptosis and autophagy by the small molecule inhibitor VMY-1-103 in cancer cell lines and reduction of tumor growth in vivo

Paul Sirajuddin, 2013 .

Design, Synthesis, and Structure−Activity Relationships of Pyridoquinazolinecarboxamides as RNA Polymerase I Inhibitors

J. Barrow, K. Peltonen, M. Laiho, 2014 .

The induction of the p53 tumor suppressor protein bridges the apoptotic and autophagic signaling pathways to regulate cell death in prostate cancer cells

Chin-Lee Wu, Richard J Lee, C. Albanese, 2014, Oncotarget.